Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPaseAlfredo Ramı́rez, Christian Kubisch, André Heimbach et al.|Nature Genetics|2006Cited by 1.2k
Nicotinamide, a Poly [ADP-Ribose] Polymerase 1 (PARP-1) Inhibitor, as an Adjunctive Therapy for the Treatment of Alzheimer’s DiseaseFelipe Salech, María Isabel Behrens|Frontiers in Aging Neuroscience|2020Cited by 85
<i>ATP13A2</i> variants in early‐onset Parkinson's disease patients and controlsAna Djarmati, Christine Klein, Johann Hagenah et al.|Movement Disorders|2009Cited by 75
A call for clinical trial globalization in Alzheimer's disease and related dementiaJorge J. Llibre‐Guerra, Ganesh M. Babulal, Anika Heavener et al.|Alzheimer s & Dementia|2023Cited by 31
Structural inequality linked to brain volume and network dynamics in aging and dementia across the AmericasAgustina Legaz, Agustín Ibáñez, Florencia Altschuler et al.|Nature Aging|2024Cited by 31